Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 10-2010 | 09-2010 | 07-2010 | 06-2010 | 04-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,094 | -2,302 | N/A | -1,208 | -2,240 |
| Depreciation Amortization | 15 | 41 | N/A | 26 | 42 |
| Accounts receivable | 1,748 | -528 | N/A | -2,276 | -735 |
| Other Working Capital | 1,036 | 134 | N/A | -902 | -506 |
| Other Operating Activity | -1,735 | 539 | 0 | 2,274 | 841 |
| Operating Cash Flow | $-31 | $-2,116 | $N/A | $-2,086 | $-2,599 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -19 | N/A | -15 | 78 |
| Investing Cash Flow | $-4 | $-19 | $N/A | $-15 | $78 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 2,067 | N/A | 2,067 | 2,450 |
| Other Financing Activity | 0 | -140 | 0 | -140 | -49 |
| Financing Cash Flow | $N/A | $1,926 | $N/A | $1,926 | $2,401 |
| Beginning Cash Position | 908 | 1,081 | N/A | 1,081 | 752 |
| End Cash Position | 873 | 873 | N/A | 908 | 633 |
| Net Cash Flow | $-35 | $-209 | $N/A | $-174 | $-120 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31 | -2,116 | N/A | -2,086 | -2,599 |
| Capital Expenditure | -4 | -19 | N/A | -15 | -26 |
| Free Cash Flow | -35 | -2,135 | 0 | -2,100 | -2,624 |